HELEN NTUNG: Open Payments
NPI 1992219661 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 26 payments from 5 companies in 2025. Trend: 2023 $67 · 2024 $1,015 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $459 |
| Janssen Pharmaceuticals, Inc | 2 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| ABBVIE INC. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
Products named: ARISTADA, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, UZEDY.
Industry payments across CA — which companies pay providers there.
